MA42022A1 - Novel peptides, peptide combinations and carriers for use in the immunotherapeutic treatment of various cancers - Google Patents
Novel peptides, peptide combinations and carriers for use in the immunotherapeutic treatment of various cancersInfo
- Publication number
- MA42022A1 MA42022A1 MA42022A MA42022A MA42022A1 MA 42022 A1 MA42022 A1 MA 42022A1 MA 42022 A MA42022 A MA 42022A MA 42022 A MA42022 A MA 42022A MA 42022 A1 MA42022 A1 MA 42022A1
- Authority
- MA
- Morocco
- Prior art keywords
- carriers
- various cancers
- novel peptides
- peptide combinations
- immunotherapeutic treatment
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 5
- 206010028980 Neoplasm Diseases 0.000 title abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
- 230000001024 immunotherapeutic effect Effects 0.000 title abstract 2
- 239000000969 carrier Substances 0.000 title 1
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 1
- 238000002619 cancer immunotherapy Methods 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La présente invention concerne des peptides, des protéines, des acides nucléiques et des cellules pour utilisation dans des procédés immunothérapeutiques. La présente invention concerne, en particulier, l'immunothérapie du cancer. La présente invention concerne, en outre, des épitopes peptidiques des lymphocytes t associés à une tumeur, seuls ou en combinaison avec d'autres peptides associés à une tumeur, qui peuvent, par exemple, servir de principes pharmaceutiques actifs pour des compositions vaccinalesThe present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. The present invention relates, in particular, to cancer immunotherapy. The present invention further relates to peptide epitopes of tumor associated t cells, alone or in combination with other tumor-associated peptides, which may, for example, serve as active pharmaceutical ingredients for vaccine compositions.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562211276P | 2015-08-28 | 2015-08-28 | |
| PCT/EP2016/070146 WO2017036936A1 (en) | 2015-08-28 | 2016-08-26 | Novel peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA42022A1 true MA42022A1 (en) | 2018-07-31 |
Family
ID=60451268
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA43091A MA43091A1 (en) | 2015-08-28 | 2016-08-26 | Novel peptides, peptide combinations and carriers for use in the immunotherapeutic treatment of various cancers |
| MA42022A MA42022A1 (en) | 2015-08-28 | 2016-08-26 | Novel peptides, peptide combinations and carriers for use in the immunotherapeutic treatment of various cancers |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA43091A MA43091A1 (en) | 2015-08-28 | 2016-08-26 | Novel peptides, peptide combinations and carriers for use in the immunotherapeutic treatment of various cancers |
Country Status (2)
| Country | Link |
|---|---|
| AR (4) | AR105851A1 (en) |
| MA (2) | MA43091A1 (en) |
-
2016
- 2016-08-26 MA MA43091A patent/MA43091A1/en unknown
- 2016-08-26 MA MA42022A patent/MA42022A1/en unknown
- 2016-08-29 AR ARP160102632A patent/AR105851A1/en not_active Application Discontinuation
-
2018
- 2018-09-21 AR ARP180102713A patent/AR113027A2/en not_active Application Discontinuation
-
2021
- 2021-05-31 AR ARP210101474A patent/AR122217A2/en not_active Application Discontinuation
- 2021-05-31 AR ARP210101475A patent/AR122218A2/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AR122218A2 (en) | 2022-08-24 |
| AR113027A2 (en) | 2020-01-15 |
| AR122217A2 (en) | 2022-08-24 |
| MA43091A1 (en) | 2019-08-30 |
| AR105851A1 (en) | 2017-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA43075A1 (en) | Novel peptides and combination of peptides for use in immunotherapy against non-Hodgkin lymphoma and other cancers | |
| MA42073A1 (en) | Novel peptides and combination of peptides for use in immunotherapy against various cancers | |
| MA42020A1 (en) | Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers | |
| MA42072A1 (en) | Novel peptides and peptide combination for use in immunotherapy against cll and other cancers | |
| MA43466A1 (en) | Treatments for uterine cancer | |
| MA42021A1 (en) | Novel peptides and peptide combination for use in immunotherapy against small cell lung cancer and other cancers | |
| MA41879A1 (en) | Novel peptides and peptide combination for use in immunotherapy against prostate cancer and other cancers | |
| MA41717A1 (en) | Novel peptides and peptide combination for use in immunotherapy against epithelial ovarian cancer and other cancers | |
| MA40813A1 (en) | Novel peptides and combination of peptides for use in immunotherapy against various tumors | |
| MA40794A1 (en) | Novel peptides and combinations of peptides and scaffolds for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers | |
| MA40713A1 (en) | Novel Peptides and Peptide Combination for Use in the Immunotherapy of Pancreatic Cancer and Other Cancers | |
| MA43618A1 (en) | Novel peptides, association of peptides as targets and intended for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers | |
| MA39907B1 (en) | New immunotherapy against several tumors, blood, including acute myeloid leukemia (lam) | |
| MA43482A1 (en) | Novel Peptides and Peptide Combination for Use in Immunotherapy for Acute Myeloid Leukemia (IMA) and Other Cancers | |
| MA43461B1 (en) | Novel peptides, peptide combinations and carriers for use in the immunotherapeutic treatment of various cancers | |
| MA43477A1 (en) | Immunotherapy against melanoma and other cancers | |
| MA41393A1 (en) | Novel peptides and peptide combinations and scaffolds formed therefor for use in immunotherapy against colorectal carcinoma (crc) and other cancers | |
| MA41521A1 (en) | Novel cell epitopes and new combination of cell epitopes for use in immunotherapy of myeloma and other cancers | |
| MA43719B1 (en) | PEPTIDE FOR USE IN IMMUNOTHERAPY AGAINST NON-SMALL CELL LUNG CANCER AND SMALL CELL LUNG CANCER | |
| MA44551A1 (en) | Novel peptides and novel combination of peptides for use in immunotherapy, and methods for generating scaffolds for use against pancreatic cancer and other cancers | |
| MA47367B1 (en) | NOVEL PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS | |
| MA42022A1 (en) | Novel peptides, peptide combinations and carriers for use in the immunotherapeutic treatment of various cancers | |
| MA46798B1 (en) | New immunotherapy against several tumors, such as lung cancer, including large cell lung cancer | |
| MA41664A1 (en) | Novel peptides and novel peptide combination for use in immunotherapy, and methods for generating scaffolds for use against pancreatic cancer and other cancers |